Get started
Author

Mikael Mansjö

Observed names: M. Mansjö, Mansjö, Mikael, Mikael Mansjo
Observed institutions: Linköping University, Public Health Agency of Sweden, Lund University, Karolinska Institutet, IRCCS Ospedale San Raffaele, IRCCS San Raffaele Roma, Umeå University
ORCID: 0000-0001-9289-351X
Observed ORCID: 0000-0001-9289-351X
OpenAlex ID: A5072929017
The 2021 WHO Catalogue of Mycobacterium Tuberculosis Complex Mutations Associated with Drug Resistance: A New Global Standard for Molecular Diagnostics
2021 · Timothy M Walker, Paolo Miotto, et al. · The Lancet Microbe · 265
PDF
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project
2016 · Matteo Zignol, Anna S Dean, et al. · The Lancet Infectious Diseases · 176
Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study
2018 · Matteo Zignol, Andrea Maurizio Cabibbe, et al. · The Lancet Infectious Diseases · 163
PDF
Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study
2014 · Paolo Miotto, Andrea M. Cabibbe, et al. · mBio · 160
Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis
2023 · Lindsay Sonnenkalb, Joshua James Carter, et al. · The Lancet Microbe · 113
PDF
Diagnostic Performance of the New Version (v2.0) of GenoType MTBDR sl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study
2015 · Elisa Tagliani, Andrea M. Cabibbe, et al. · Journal of Clinical Microbiology · 111
PDF
The Riboflavin analog Roseoflavin targets an FMN-riboswitch and blocksListeria monocytogenes growth, but also stimulates virulence gene-expression and infection
2011 · Mikael Mansjö, Jörgen Johansson · RNA Biology · 85
PDF
Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach
2024 · Ivan Barilar, Simone Battaglia, et al. · Nature Communications · 58
PDF
Non- pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?
2017 · Jim Werngren, Erik Alm, et al. · Journal of Clinical Microbiology · 54
PDF
An association study of NRAMP1, VDR, MBL and their interaction with the susceptibility to tuberculosis in a Chinese population
2015 · Linlin Wu, Haijun Deng, et al. · International Journal of Infectious Diseases · 49
PDF
Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis
2021 · Samuel J. Modlin, Tyler Marbach, et al. · Antimicrobial Agents and Chemotherapy · 23
Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting
2018 · Katarina Niward, Lina Davies Forsman, et al. · Journal of Antimicrobial Chemotherapy · 21
PDF
Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China
2016 · Dange Li, Yi Hu, et al. · Antimicrobial Agents and Chemotherapy · 21
Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China
2016 · Xubin Zheng, Rongrong Zheng, et al. · Antimicrobial Agents and Chemotherapy · 21
PDF
Distribution of Common and Rare Genetic Markers of Second-Line-Injectable-Drug Resistance in Mycobacterium tuberculosis Revealed by a Genome-Wide Association Study
2022 · Derek Conkle-Gutierrez, Calvin Kim, et al. · Antimicrobial Agents and Chemotherapy · 19
PDF
Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophages
2017 · Jonna Idh, Blanka Andersson, et al. · PLoS ONE · 19
PDF
Experiences from 4 Years of Organization of an External Quality Assessment for Mycobacterium tuberculosis Whole-Genome Sequencing in the European Union/European Economic Area
2022 · R. M. Anthony, E. Tagliani, et al. · Microbiology Spectrum · 18
Performance of a broth microdilution assay for routine minimum inhibitory concentration determination of 14 anti-tuberculous drugs against the Mycobacterium tuberculosis complex based on the EUCAST reference protocol
2024 · Mikael Mansjö, Carmen Espinosa-Gongora, et al. · Antimicrobial Agents and Chemotherapy · 16
Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosis
2024 · Johanna Kuhlin, Lina Davies Forsman, et al. · International Journal of Antimicrobial Agents · 16
Multi-center evaluation of GenoType MTBDRsl line probe assay for rapid detection of pre-XDR and XDR Mycobacterium tuberculosis in China
2018 · Yazhou Gao, Zhengdong Zhang, et al. · Journal of Infection · 16
Detection of Pyrazinamide Heteroresistance in Mycobacterium tuberculosis
2021 · Jim Werngren, Mikael Mansjö, et al. · Antimicrobial Agents and Chemotherapy · 15
High Prevalence of SARS-CoV-2 Omicron Infection Despite High Seroprevalence, Sweden, 2022
2023 · Ramona Groenheit, Philip Bacchus, et al. · Emerging infectious diseases · 14
Systematic Review of Whole-Genome Sequencing Data To Predict Phenotypic Drug Resistance and Susceptibility in Swedish Mycobacterium tuberculosis Isolates, 2016 to 2018
2020 · Theresa Enkirch, Jim Werngren, et al. · Antimicrobial Agents and Chemotherapy · 14
Pyrazinamide-resistant Tuberculosis Obscured From Common Targeted Molecular Diagnostics
2023 · Samuel J. Modlin, Mikael Mansjö, et al. · Drug Resistance Updates · 13
Minimum Inhibitory Concentrations of Fluoroquinolones and Pyrazinamide Susceptibility Correlate to Clinical Improvement in Multidrug-resistant Tuberculosis Patients: A Nationwide Swedish Cohort Study Over 2 Decades
2018 · Lina Davies Forsman, Jerker Jonsson, et al. · Clinical Infectious Diseases · 13
Works count: 49
Citation count: 1,601
H-index: 17
I10-index: 29
Year
Topic
Type